We suggest that all patients negative for COL1A1/2 pathogenic variants be tested for the presence of an IFITM5 pathogenic variant, even if they are not expressing typical OI type V symptoms. This evidence concerns the gene COL1A1 and osteogenesis imperfecta type 5.